Psychoactive substances, users and markets in France in 2021. Assessment of developments in use and access to care, marked by the health crisis linked to Covid-19
In a glimpse, OFDT, 2 p.
January 2023
Tendances No. 154 looks back on the development of freebase cocaine use among the most vulnerable drug users and their difficulties in accessing care during 2021, a year marked by the measures taken in response to the Covid-19 pandemic. It reports on the distribution processes of 3-MMC and ketamine within techno party environments, then examines the evolution of consumption in the context of chemsex and its social and health-related consequences.
Download
Drugs in Europe
2023 EMCDDA European Drug Report
The European Drug Report 2023: Trends and Developments presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions. This report is based on information provided to the EMCDDA by the EU Member States, the candidate country Türkiye, and Norway, in an annual reporting process.
The annual Statistical Bulletin contains the most recent available data on the drug situation in Europe provided by the Member States. These datasets underpin the analysis presented in the European Drug Report. All data may be viewed interactively on screen and downloaded in Excel format.
The European Union and the drug phenomenon
The European Union & the drug phenomenon : Frequently asked questions, joint publication between the EMCDDA and the European Commission, october 2010, 12 p.
